Glaser Carol A, Gilliam Sabrina, Honarmand Somayeh, Tureen Jay H, Lowenstein Daniel H, Anderson Larry J, Bollen Andrew W, Solbrig Marylou V
Viral and Rickettsial Disease Branch, California Department of Public Health, 850 Marina Bay Parkway, Richmond, CA 94804, USA.
Neurocrit Care. 2008;9(1):74-82. doi: 10.1007/s12028-007-9042-y.
The California Encephalitis Project (CEP) is a program designed to determine causes of encephalitis. We sought to determine whether there are any distinguishing characteristics of patients with encephalitis who develop refractory status epilepticus from those who do not.
Data from all patients in the CEP were retrospectively reviewed and analyzed. Diagnostic testing was performed for a panel of infectious agents and medical information collected using a standardized form. Encephalitis patients were subdivided into three categories: (i) patients with status epilepticus unresponsive to standard antiepileptic therapy who required general anesthetic coma for management (Group I), (ii) patients with seizures or status epilepticus responsive to standard antiepileptic therapy (Group II), and (iii) patients without seizures (Group III). Supplementary information was requested on Group I patients.
Of 1,151 patients; 43 (4%) were classified as Group I, 459 (40%) as Group II, and 649 (56%) as Group III. Compared to Groups II and III, Group I patients were younger (median age = 10.0 years), more likely to have fever (93%), prodromal respiratory (57%) or gastrointestinal illness (64%), and less likely to have CSF pleocytosis (47%) or abnormal neuroimaging (16%). A causative infectious agent was verified in three of the Group I patients; and a putative agent in nine others. Supplementary information on Group I revealed that 28% died within 2 years and 56% were neurologically impaired or undergoing rehabilitation.
Encephalitis and refractory status epilepticus occur most commonly in the pediatric age group, an infectious etiology is usually not established, and outcomes are generally poor.
加利福尼亚脑炎项目(CEP)是一项旨在确定脑炎病因的计划。我们试图确定发生难治性癫痫持续状态的脑炎患者与未发生者之间是否存在任何区别特征。
对CEP中所有患者的数据进行回顾性审查和分析。针对一组传染原进行诊断检测,并使用标准化表格收集医疗信息。脑炎患者被分为三类:(i)对标准抗癫痫治疗无反应、需要全身麻醉昏迷来处理的癫痫持续状态患者(第一组),(ii)对标准抗癫痫治疗有反应的癫痫发作或癫痫持续状态患者(第二组),以及(iii)无癫痫发作的患者(第三组)。向第一组患者索要补充信息。
在1151名患者中,43名(4%)被归类为第一组,459名(40%)为第二组,649名(56%)为第三组。与第二组和第三组相比,第一组患者更年轻(中位年龄 = 10.0岁),更易出现发热(93%)、前驱性呼吸道疾病(57%)或胃肠道疾病(64%),而脑脊液细胞增多(47%)或神经影像学异常(16%)的可能性较小。在第一组的3名患者中证实了有致病传染原,另外9名患者中有假定的传染原。关于第一组的补充信息显示,28%的患者在2年内死亡,56%的患者有神经功能障碍或正在接受康复治疗。
脑炎和难治性癫痫持续状态最常发生在儿童年龄组,通常无法确定感染病因,且总体预后较差。